TSAAI 2022 Annual Meeting
It is an exciting time in the field of allergy and immunology! This CME program is designed to allow attendees to continue exploring the Immunology Frontier. Covered topics include Asthma, Antibody Deficiencies, Using Biologics, COVID Vaccines, Chronic Cough, Dematology and Hymenoptera Hypersensistivity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American College of Allergy, Asthma & Immunology (ACAAI) and Tennessee Society of Allergy, Asthma and Immunology. The American College of Allergy, Asthma and Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 7 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity
This activity is supported in part by a medical education grant from CSL Behring and Takeda.
Allied health professionals
Upon completion of this activity the participant should be able to:
- Discuss steps/approaches to align the effects individual biologics with characteristics and needs of specific asthma patients
- Recognize the clinical presentation of aspirin-exacerbated respiratory disease and distinguish it from aspirin-tolerant asthma
- Demonstrate competence in allergen selection and administration in successful cluster and rush subcutaneous immunotherapy (SCIT) regimens
- 7.00 AMA PRA Category 1 Credit™
- 7.00 Attendance